Evidence map›Paper›PMID 26599624›Full record

ArticleBiomaterials2016

Heterogeneous engineered cartilage growth results from gradients of media-supplemented active TGF-β and is ameliorated by the alternative supplementation of latent TGF-β.

Michael B Albro, Robert J Nims, Krista M Durney, Alexander D Cigan, Jay J Shim, Gordana Vunjak-Novakovic, Clark T Hung, Gerard A Ateshian

Open access · greenAbstract readComparative Study
In one paragraph

Article in Biomaterials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Autoinduction-Based Quantification ofTissue engineering. Part C, Methods · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Michael B Albro *Department of Materials, Imperial College London, London, UK.
Robert J Nims *Department of Biomedical Engineering, Columbia University, New York, NY 10027.
Krista M DurneyDepartment of Biomedical Engineering, Columbia University, New York, NY 10027.
Alexander D CiganDepartment of Biomedical Engineering, Columbia University, New York, NY 10027.
Jay J ShimDepartment of Mechanical Engineering, Columbia University, New York, NY 10027.
Gordana Vunjak-NovakovicDepartment of Biomedical Engineering, Columbia University, New York, NY 10027.
Clark T HungDepartment of Biomedical Engineering, Columbia University, New York, NY 10027.
Gerard A AteshianDepartment of Biomedical Engineering, Columbia University, New York, NY 10027.
Columbia University · USImperial College London · GB

Funding

Finite Elements For Biomechanics And BiophysicsR01GM083925 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI GERARD A. ATESHIAN, JEFFREY A. WEISS · 2008 to 2026
$7.6M
Craniofacial Tissue EngineeringR01DE016525 · NIDCR · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI VUNJAK-NOVAKOVIC, GORDANA · 2005 to 2017
$5.5M
BIOTRIBOLOGY OF DIARTHRODIAL JOINTSR01AR043628 · NIAMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ATESHIAN, GERARD A. · 2000 to 2013
$3.1M
Optimizing Nutrient Supply in Large Engineered Cartilage Tissue ConstructsR01AR060361 · NIAMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ATESHIAN, GERARD A., HUNG, CLARK T. · 2010 to 2014
$1.7M
BIOTRIBOLOGY OF DIARTHRODIAL JOINTSR29AR043628 · NIAMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ATESHIAN, GERARD A. · 1995 to 1999
–
NIAMS NIH HHS AR043628NIAMS NIH HHS AR060361NIAMS NIH HHS R01 AR043628NIAMS NIH HHS R01 AR060361NIAMS NIH HHS R29 AR043628NIDCR NIH HHS R01 DE016525NIGMS NIH HHS GM083925NIGMS NIH HHS R01 GM083925
6 · The paper itself

Abstract

Transforming growth factor beta (TGF-β) has become one of the most widely utilized mediators of engineered cartilage growth. It is typically exogenously supplemented in the culture medium in its active form, with the expectation that it will readily transport into tissue constructs through passive diffusion and influence cellular biosynthesis uniformly. The results of this investigation advance three novel concepts regarding the role of TGF-β in cartilage tissue engineering that have important implications for tissue development. First, through the experimental and computational analysis of TGF-β concentration distributions, we demonstrate that, contrary to conventional expectations, media-supplemented exogenous active TGF-β exhibits a pronounced concentration gradient in tissue constructs, resulting from a combination of high-affinity binding interactions and a high cellular internalization rate. These gradients are sustained throughout the entire culture duration, leading to highly heterogeneous tissue growth; biochemical and histological measurements support that while biochemical content is enhanced up to 4-fold at the construct periphery, enhancements are entirely absent beyond 1 mm from the construct surface. Second, construct-encapsulated chondrocytes continuously secrete large amounts of endogenous TGF-β in its latent form, a portion of which undergoes cell-mediated activation and enhances biosynthesis uniformly throughout the tissue. Finally, motivated by these prior insights, we demonstrate that the alternative supplementation of additional exogenous latent TGF-β enhances biosynthesis uniformly throughout tissue constructs, leading to enhanced but homogeneous tissue growth. This novel demonstration suggests that latent TGF-β supplementation may be utilized as an important tool for the translational engineering of large cartilage constructs that will be required to repair the large osteoarthritic defects observed clinically.

Indexed as

AnimalsAutocrine CommunicationCartilageCattleCell Culture TechniquesCells, CulturedChondrocytesComputer SimulationCulture MediaDose-Response Relationship, DrugExtracellular Matrix ProteinsHumansMesenchymal Stem CellsModels, BiologicalOrganoidsOsmolar ConcentrationCulture MediaExtracellular Matrix ProteinsRecombinant ProteinsTransforming Growth Factor beta1Transforming Growth Factor beta3Biochemical gradientsCartilage tissue engineeringFinite element modelGrowth factor deliveryHeterogeneous growthTransforming growth factor beta

Identifiers

PMID26599624
PMCPMC4968414
OpenAlexW2199965127

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.